CN114899344A - Organic electroluminescent device - Google Patents

Organic electroluminescent device Download PDF

Info

Publication number
CN114899344A
CN114899344A CN202210763276.XA CN202210763276A CN114899344A CN 114899344 A CN114899344 A CN 114899344A CN 202210763276 A CN202210763276 A CN 202210763276A CN 114899344 A CN114899344 A CN 114899344A
Authority
CN
China
Prior art keywords
different
same
substituted
present
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210763276.XA
Other languages
Chinese (zh)
Other versions
CN114899344B (en
Inventor
董秀芹
孙月
刘小婷
陆影
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changchun Hyperions Technology Co Ltd
Original Assignee
Changchun Hyperions Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changchun Hyperions Technology Co Ltd filed Critical Changchun Hyperions Technology Co Ltd
Publication of CN114899344A publication Critical patent/CN114899344A/en
Application granted granted Critical
Publication of CN114899344B publication Critical patent/CN114899344B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/18Carrier blocking layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/623Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing five rings, e.g. pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/624Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing six or more rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention provides an organic electroluminescent device, and belongs to the technical field of organic electroluminescence. The organic electroluminescent device provided by the invention can control the injection rate of holes from the hole transport layer to the electron blocking layer, avoids excessive and too fast transmission of holes to the electron blocking layer, solves the problem of accumulation of holes between the electron blocking layer and the light emitting layer, and can improve the condition that a recombination region is close to one side of the electron blocking layer, so that the holes are effectively limited in the light emitting layer to be recombined with electrons to form exciton luminescence, thereby improving the luminous efficiency of the organic electroluminescent device and prolonging the service life of the device. The organic electroluminescent device has good application effect and industrialization prospect.

Description

Organic electroluminescent device
Technical Field
The invention relates to the technical field of organic electroluminescence, in particular to an organic electroluminescent device.
Background
An Organic Light-Emitting Diode (OLED) refers to a device in which an Organic semiconductor material and a Light-Emitting material are driven by an electric field and injected and combined with carriers. When a voltage is applied to the device, holes and electrons from the anode and the cathode are injected, respectively, and the injected holes and electrons are recombined in the light-emitting layer to form excitons, and light is emitted when the excitons transition to the ground state. At this time, the OLED may be classified into a fluorescent device in which singlet excitons participate in light emission and a phosphorescent device in which triplet excitons participate in light emission according to the kind of electron spin of the formed excitons.
The device structure of an OLED is similar to a "sandwich", i.e. an organic functional layer is sandwiched between two electrodes. Organic functional layers can be further classified into single-layer, double-layer, three-layer, and multilayer device structures according to the number of layers. A single layer structure means that only one layer of light emitting material is contained between two electrodes. The double-layer structure device has one more layer of transmission material to balance the difference of carrier transmission. Tri-layer devices may use both hole transport layers and electron transport layers to further balance the transport of carriers. The multilayer device is formed by adding an injection layer material and/or a blocking layer material outside a three-layer structure to increase the injection of carriers and/or block excessive carriers, so that the exciton recombination region and the light-emitting layer are enabled to be overlapped greatly. Because functional layers in the multilayer device are mutually matched but independently work, a plurality of convenience is provided for the performance optimization of the device, and the multilayer structure is a common structure for preparing the OLED device at present.
With the continuous development of OLED products, the requirements for the efficiency, the service life and other properties of the OLED products are higher and higher. The performance of the device mainly depends on the material performance of each film layer and the matching structure of the device, the material direction mainly considers the material mobility, the material stability, the material fluorescence quantum yield (PLQY) and the like, and the matching structure direction mainly considers the energy level matching, the exciton distribution condition, the electron and hole injection and accumulation condition and the like of the adjacent film layers. For the problems of low device efficiency and lifetime, it is currently believed that the main problem is the deviation of the recombination zone between the electron blocking layer/light emitting layer. Therefore, how to limit the exciton recombination region of the device in the light-emitting layer is a problem to be solved urgently at present.
Disclosure of Invention
As holes in the conventional device are too many and are transmitted into the electron blocking layer/luminescent layer too fast, the recombination region of excitons is close to one side of the electron blocking layer, so that the luminescent efficiency and the service life of the device are greatly reduced. In order to solve the above problems, the present invention provides an organic electroluminescent device, which can effectively improve the luminous efficiency and the service life of the organic electroluminescent device.
The invention provides an organic electroluminescent device, which comprises: an anode and a cathode which are oppositely arranged, a light-emitting layer which is positioned between the anode and the cathode, an electron-blocking layer which is positioned between the light-emitting layer and the anode, and a hole-transporting layer which is positioned between the electron-blocking layer and the anode, wherein the HOMO energy level of the electron-blocking layer is equal to or less than the HOMO energy level of the hole-transporting layer, and the absolute value of the difference between the HOMO value of the hole-transporting layer and the HOMO value of the electron-blocking layer is greater than or equal to 0eV and less than or equal to 0.25eV,
Figure BDA0003724720390000021
in formula 1, Ar is 1 、Ar 2 The same or different is selected from any one of the structures shown below,
Figure BDA0003724720390000022
ring a is selected from a substituted or unsubstituted spirocyclic structure;
the R is 1 -R 5 The same or different is selected from hydrogenAny one of substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, and substituted or unsubstituted C6-C18 aryl;
a is a mentioned 1 Selected from 0,1, 2,3, 4 or 5; a is a 2 Selected from 0,1, 2 or 3; a is a 3 Selected from 0,1, 2,3 or 4; when two or more R's are present 1 When two or more R are present 1 Are the same or different from each other, or two adjacent R 1 Are connected with each other to form a substituted or unsubstituted ring; when two or more R's are present 5 When two or more R are present 5 Are the same or different from each other, or two adjacent R 5 Are connected with each other to form a substituted or unsubstituted ring;
n is 1 Selected from 1,2 or 3;
the R is 0 The same or different compounds are selected from any one of hydrogen, deuterium, tritium, C1-C6 alkyl and C6-C12 aryl; the R is 0 May be substituted by one or more substituents which may be the same or different and are selected from any one of deuterium, tritium, an alkyl group of C1 to C12, and an aryl group of C6 to C12;
n is 2 Selected from 0,1, 2,3 or 4; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other, or two adjacent R 0 Are connected with each other to form a substituted or unsubstituted alicyclic ring;
the above-mentioned
Figure BDA0003724720390000023
Containing at least one deuterium or tritium;
the Ra and the Rb are the same or different and are selected from any one of hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C12 aryl;
m is 1 Selected from 0,1, 2,3 or 4; when two or more Ra are present, the two or more Ra are the same or different from each other, or two adjacent Ra are linked to each other to form a substituted or unsubstituted benzene ring;
m is 2 Selected from 0,1, 2 or 3; when two or more Rb are present, the two or more Rb may be the same or different from each other, or two adjacent Rb may be linked to each other to form a substituted or unsubstituted benzene ring;
ar is 3 Any one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C18 aryl;
said L 1 、L 2 The same or different arylene groups are selected from single bond, substituted or unsubstituted arylene groups of C6-C18.
The invention has the beneficial effects that:
the organic electroluminescent device provided by the invention is characterized in that the absolute value delta E1 of the difference between the HOMO value of the hole transport layer and the HOMO value of the electron blocking layer is more than or equal to 0eV and less than or equal to 0.25eV, meanwhile, the structure of formula 1 is used as a hole transport layer material, and the structure of formula 2 is used as an electron blocking layer material, which can help to control the injection rate of holes from the hole transport layer to the electron blocking layer, and avoid the excessive and fast transmission of holes to the electron blocking layer, so as to solve the problem of accumulation of holes between the electron blocking layer/the light emitting layer, meanwhile, the situation that the recombination region is close to one side of the electron blocking layer can be improved, so that holes are effectively limited in the luminescent layer to be recombined with electrons to form exciton luminescence, and the exciton recombination region moves to the center of the luminescent layer, thereby improving the luminous efficiency of the organic electroluminescent device and prolonging the service life of the device.
Drawings
Fig. 1 is a schematic structural diagram of an organic electroluminescent device provided in an embodiment of the present disclosure;
fig. 2 is a schematic diagram of an energy level relationship of an organic electroluminescent device provided in an embodiment of the present disclosure.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the drawings of the embodiments of the present invention. It is to be understood that the embodiments described are only a few embodiments of the present invention, and not all embodiments. And the embodiments and features of the embodiments may be combined with each other without conflict. All other embodiments, which can be derived by a person skilled in the art from the described embodiments of the invention without any inventive step, are within the scope of protection of the invention.
Unless defined otherwise, technical or scientific terms used herein shall have the ordinary meaning as understood by one of ordinary skill in the art to which this invention belongs. The use of the terms "comprising" or "including" and the like in the present invention, means that the element or item presented before the term covers the element or item listed after the term and its equivalents, but does not exclude other elements or items. The terms "connected" or "coupled" and the like are not restricted to physical or mechanical connections, but may include electrical connections, whether direct or indirect. "inner", "outer", "upper", "lower", and the like are used merely to indicate relative positional relationships, and when the absolute position of the object being described is changed, the relative positional relationships may also be changed accordingly.
In the compounds of the present invention, any atom not designated as a particular isotope is included as any stable isotope of that atom and includes atoms in both their natural isotopic abundance and unnatural abundance.
In the context of the present specification,
Figure BDA0003724720390000031
means a moiety attached to another substituent.
In the present specification, "" means a moiety linked to another substituent.
In the present specification, when the position of a substituent or attachment site on an aromatic ring is not fixed, it means that it can be attached to any of the corresponding optional sites of the aromatic ring. For example,
Figure BDA0003724720390000032
can represent
Figure BDA0003724720390000033
And so on.
In the present specification, when a bond at a substituent or attachment site is present throughout two or more rings, it is indicated that it may be attached to either of the two or two rings, in particular to either of the corresponding alternative sites of the rings. For example,
Figure BDA0003724720390000041
can represent
Figure BDA0003724720390000042
Or
Figure BDA0003724720390000043
Can represent
Figure BDA0003724720390000044
Can represent
Figure BDA0003724720390000045
Or
Figure BDA0003724720390000046
Can represent
Figure BDA0003724720390000047
And so on.
The alkyl group in the present invention refers to a monovalent group formed by subtracting one hydrogen atom from an alkane molecule, and may be a straight-chain alkyl group, a branched-chain alkyl group, preferably having 1 to 25 carbon atoms, preferably 1 to 12 carbon atoms, more preferably 1 to 10 carbon atoms, and particularly preferably 1 to 6 carbon atoms, and examples may include a methyl group, an ethyl group, a propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isopentyl group, a hexyl group, and the like, but are not limited thereto.
The alicyclic group in the present invention means a monovalent group formed by removing one hydrogen atom from an alicyclic hydrocarbon molecule, and may be a cycloalkyl group, a cycloalkenyl group, a cycloalkynyl group, etc., preferably having 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, an adamantyl group, a norbornyl group, a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, etc., but are not limited thereto.
The cycloalkyl group in the present invention means a monovalent group formed by subtracting one hydrogen atom from a cycloalkane molecule, and preferably has 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, adamantyl, norbornyl and the like, but is not limited thereto.
The cycloalkenyl group in the present invention means a monovalent group formed by dropping one hydrogen atom from a cycloolefin molecule, and preferably has 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl and the like, but are not limited thereto.
The heterocycloalkyl group in the invention is a univalent group formed by subtracting one hydrogen atom from a heterocycloalkyl molecule, and the heteroatom can be one or more of N, O, S, Si and P. Preferably having 1 to 25 carbon atoms, more preferably 2 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 5 carbon atoms, and examples may include azetidinyl, tetrahydropyrrolyl, tetrahydrofuryl, tetrahydrothienyl, piperidinyl, azepinyl, homopiperidinyl, morpholinyl, thiomorpholinyl, dioxane, and the like, but are not limited thereto.
The aryl group in the present invention refers to a monovalent group obtained by removing one hydrogen atom from an aromatic core carbon of an aromatic hydrocarbon molecule, and may be a monocyclic aryl group, a polycyclic aryl group or a condensed ring aryl group, preferably having 6 to 30 carbon atoms, preferably 6 to 18 carbon atoms, more preferably 6 to 14 carbon atoms, and most preferably 6 to 12 carbon atoms, and examples may include a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, an indenyl group, a dihydroindenyl group, a dihydronaphthyl group, a tetrahydronaphthyl group, an anthryl group, a phenanthryl group, a pyrenyl group, a triphenylene group, a perylenyl group, and the like, but are not limited thereto.
The fused cyclic group of the alicyclic ring and the aromatic ring in the invention refers to a general name of a monovalent group left by removing one hydrogen atom after the alicyclic ring and the aromatic ring are fused together. Preferably having 7 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, most preferably 7 to 13 carbon atoms, and examples may include benzocyclopropyl, benzocyclobutyl, benzocyclopentyl, benzocyclohexyl, benzocycloheptyl, benzocyclopentenyl, benzocycloheptenyl, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, and the like, but are not limited thereto.
The fused cyclic group of the heterocyclic alkane and the aromatic ring is a general name of a monovalent group which is left after the heterocyclic alkane and the aromatic ring are fused together and a hydrogen atom is removed. Preferably having 6 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, most preferably 7 to 13 carbon atoms, and examples may include, but are not limited to, benzoazetidinyl, benzotetrahydropyrrolyl, benzopiperidinyl, benzoazepanyl, naphthotetrahydropyrrolyl, naphthopiperidinyl, phenanthrylpyrrolyl, phenanthrylpiperidinyl, and the like.
The heteroaryl group in the present invention is a general term for a monovalent group obtained by removing a hydrogen atom from a nuclear atom of an aromatic heterocyclic ring composed of carbon and a hetero atom. The hetero atom may be one or more of N, O, S, Si, P, may be a monocyclic heteroaryl group or a fused heteroaryl group, preferably having 1 to 30 carbon atoms, preferably 2 to 20 carbon atoms, more preferably 2 to 16 carbon atoms, particularly preferably 3 to 12 carbon atoms, most preferably 3 to 8 carbon atoms, and examples may include pyrrolyl, pyridyl, pyrimidinyl, triazinyl, thienyl, furyl, indolyl, quinolyl, isoquinolyl, oxazolyl, thiazolyl, imidazolyl, benzothienyl, benzofuryl, benzoxazolyl, benzothiazolyl, benzimidazolyl, pyridooxazolyl, pyridothiazolyl, pyridoimidazolyl, pyrimidoxazolyl, pyrimidozolyl, pyrimido thiazolyl, pyrimido imidazolyl, dibenzofuryl, dibenzothienyl, carbazolyl, phenazinyl, quinoxalinyl, quinazolinyl, quinoxalyl, Quinolinothiazolyl, quinolinoimidazolyl, purinyl, 2-purinyl, N-imidazolyl, and the like, but is not limited thereto.
The fused cyclic group of the alicyclic ring and the heteroaromatic ring in the invention is a general term for removing one hydrogen atom after the alicyclic ring and the heteroaromatic ring are fused together to leave a monovalent group. Preferably having 5 to 30 carbon atoms, more preferably 5 to 18 carbon atoms, most preferably 5 to 12 carbon atoms, and examples may include pyridocyclopropyl, pyridocyclobutyl, pyridocyclopentyl, pyridocyclohexyl, pyridocycloheptyl, pyrimidocyclopropyl, pyrimidocyclobutyl, pyrimidocyclopentyl, pyrimidocyclohexyl, pyrimidocycloheptyl, dibenzofurocyclopropyl, dibenzofurocyclobutyl, dibenzofurocyclopentyl, dibenzofurocyclohexyl, dibenzofurocycloheptyl, dibenzothienocyclopropyl, dibenzothienocyclobutyl, dibenzothienocyclopentyl, dibenzothienocyclohexyl, dibenzothienocycloheptyl, carbazolocyclopropyl, carbazolocyclobutyl, carbazolocyclopentyl, carbazolocyclohexyl, carbazolocycloheptyl, and the like, but are not limited thereto.
The arylene group in the present invention refers to a general term of divalent groups remaining after two hydrogen atoms are removed from an aromatic nucleus of an aromatic hydrocarbon molecule, and may be monocyclic arylene group, polycyclic arylene group or condensed ring arylene group, preferably having 6 to 30 carbon atoms, preferably 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, particularly preferably 6 to 18 carbon atoms, and most preferably 6 to 12 carbon atoms, and examples may include phenylene, biphenylene, terphenylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene, triphenylene, peryleneene, and the like, but are not limited thereto.
The alicyclic group in the present invention means a divalent group in which two hydrogen atoms are omitted from an alicyclic hydrocarbon molecule, and may be a cycloalkylene group, a cycloalkenylene group, or the like, preferably having 3 to 25 carbon atoms, more preferably 3 to 20 carbon atoms, particularly preferably 3 to 15 carbon atoms, preferably 3 to 12 carbon atoms, preferably 3 to 7 carbon atoms, and examples may include, but are not limited to, a cyclopropylene group, a cyclobutylene group, a cyclopentylene group, a cyclohexylene group, a cycloheptylene group, an adamantylene group, a norbornane group, a cyclopropenylene group, a cyclobutenyl group, a cyclopentenylene group, a cyclohexenylene group, a cycloheptenylene group, or the like.
The term "fused ring group" of an alicyclic ring and an aromatic ring as used herein refers to a general term in which an alicyclic ring and an aromatic ring are fused together and then two hydrogen atoms are removed to leave a divalent group. Preferably having 7 to 30 carbon atoms, more preferably 7 to 18 carbon atoms, most preferably 7 to 13 carbon atoms, and examples may include benzocyclobutene, benzocyclopentylene, benzocyclohexylene, benzocycloheptyl, benzocyclopentylene, benzocyclohexylene, benzocycloheptylene, naphthocyclopropyl, naphthocyclobutyl, naphthocyclopentyl, naphthocyclohexyl, and the like, but are not limited thereto.
The "substitution" as referred to herein means that a hydrogen atom in a compound group is replaced with another atom or group, and the position of substitution is not limited.
The "substituted or unsubstituted" as referred to herein means not substituted or substituted with one or more substituents selected from the group consisting of: protium, deuterium, tritium, cyano, halogen atom, amino, nitro, substituted or unsubstituted C-C alkyl, substituted or unsubstituted C-C alicyclic, substituted or unsubstituted C-C heterocycloalkyl, substituted or unsubstituted C-C aryl, substituted or unsubstituted C-C alicyclic and C-C aromatic ring fused ring groups, substituted or unsubstituted C-C heterocyclic alkane and C-C aromatic ring fused ring groups, substituted or unsubstituted C-C heteroaryl, substituted or unsubstituted C-C alicyclic and C-C heteroaromatic ring fused ring groups, substituted or unsubstituted C-C aromatic amine group, substituted or unsubstituted C-C aryloxy, preferably protium, deuterium, tritium, halogen atom, cyano, C-C alkyl, C-C alicyclic, C-C aryl, C-C heteroaryl, and specific examples may include protium, deuterium, tritium, halogen atom, amino, nitro, C-C alkyl, C-C fused ring groups, C-C aromatic ring fused ring groups, substituted or unsubstituted C-C aromatic ring groups, and C-C aromatic ring fused ring groups, and specific examples may include protium, and C-C fused ring, Deuterium, tritium, fluorine, chlorine, bromine, iodine, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, cyclopentenyl, cyclohexenyl, benzocyclobutenyl, benzocyclopentyl, benzocyclohexyl, benzocyclopentaenyl, benzocyclohexenyl, phenylcyclohexenyl, methyl, ethyl, isopropyl, n-butyl, tert-butyl, cyclopentyl, cyclohexyl, phenylcyclohexenyl, and phenylcyclohexenylTolyl, mesityl, pentadeuterophenyl, biphenyl, naphthyl, anthryl, phenanthryl, benzophenanthryl, pyrenyl, triphenylene, biphenyl, phenanthryl, phenyl, and the like,
Figure BDA0003724720390000062
A phenyl group, a perylene group, a fluoranthenyl group, a 9, 9-dimethylfluorenyl group, a 9, 9-diphenylfluorenyl group, a 9-methyl-9-phenylfluorenyl group, a carbazolyl group, a 9-phenylcarbazolyl group, a spirobifluorenyl group, a carbazoloindolyl group, a pyrrolyl group, a furyl group, a thienyl group, an indolyl group, a benzofuryl group, a benzothienyl group, a dibenzofuryl group, a dibenzothienyl group, a pyridyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, an oxazolyl group, a thiazolyl group, an imidazolyl group, a benzoxazolyl group, a benzothiazolyl group, a benzotriazolyl group, a benzimidazolyl group, a pyridooxazolyl group, a pyridothiazolyl group, a pyridoimidazolyl group, a pyrimido oxazolyl group, a pyrimido imidazolyl group, a quinolyl group, an isoquinolyl group, a quinolonooxazolyl group, a quinolothiazolyl group, a phenothiazinyl group, a phenoxazinyl group, Acridinyl, and the like, but are not limited thereto. Or when the substituents are two or more, adjacent substituents may be bonded to form a ring; when the substituents are two or more, the substituents may be the same as or different from each other.
The linking to form a substituted or unsubstituted ring according to the present invention means that the two groups are linked to each other by a chemical bond and optionally aromatized. As exemplified below:
Figure BDA0003724720390000061
in the present invention, the ring formed by the connection may be a five-membered ring or a six-membered ring or a fused ring, and examples may include benzene, pyridine, pyrimidine, naphthalene, fluorene, cyclopentene, cyclohexene, cyclopentane, cyclohexane acene, quinoline, isoquinoline, dibenzothiophene, phenanthrene or pyrene, but are not limited thereto.
The invention provides an organic electroluminescent device, which comprises: an anode and a cathode which are oppositely arranged, a light-emitting layer which is positioned between the anode and the cathode, an electron blocking layer which is positioned between the light-emitting layer and the anode, and a hole transport layer which is positioned between the electron blocking layer and the anode, wherein the HOMO energy level of the electron blocking layer is equal to or less than the HOMO energy level of the hole transport layer, and the absolute value of the difference between the HOMO value of the hole transport layer and the HOMO value of the electron blocking layer is greater than or equal to 0eV and less than or equal to 0.25 eV.
Preferably, the absolute value of the difference between the HOMO value of the hole transport layer and the HOMO value of the electron blocking layer is greater than or equal to 0.03eV and less than or equal to 0.24 eV.
An organic electroluminescent device according to the present invention, schematically illustrated in fig. 1 and 2, includes: an anode 1 and a cathode 2 arranged oppositely, a light-emitting layer 3 located between the anode 1 and the cathode 2, the luminescent layer 3 comprises a host material and a doping material, an electron blocking layer 4 positioned between the luminescent layer 3 and the anode 1, a hole transport layer 5 positioned between the electron blocking layer 4 and the anode 1, the HOMO level of the electron blocking layer 4 is equal to or less than the HOMO level of the hole transport layer 5, the absolute value of the difference between the HOMO value of the hole transport layer 5 and the HOMO value of the electron blocking layer 4 is greater than or equal to 0eV and less than or equal to 0.25eV, this energy level relationship facilitates both the control of the injection rate of holes from the hole transport layer 5 into the electron blocking layer 4 and the transport of holes over the light-emitting layer 3, thereby, holes are effectively confined in the light emitting layer 3 to be recombined with electrons to form exciton luminescence, and the exciton recombination region moves to the center of the light emitting layer 3. The combined action of the two aspects effectively avoids the accumulation of the holes at the interface of the luminescent layer 3 and the electron blocking layer 4, and enables the holes to better move towards the interior of the luminescent layer 3, thereby improving the efficiency and the service life of the organic electroluminescent device.
The material of the hole transport layer of the present invention is selected from the structure shown in formula 1 below,
Figure BDA0003724720390000071
in formula 1, Ar is 1 、Ar 2 The same or different optionsFrom any of the configurations shown below,
Figure BDA0003724720390000072
ring a is selected from a substituted or unsubstituted spirocyclic structure;
the R is 1 -R 5 The same or different hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C6-C18 aryl;
a is a 1 Selected from 0,1, 2,3, 4 or 5; a is a 2 Selected from 0,1, 2 or 3; a is a 3 Selected from 0,1, 2,3 or 4; when two or more R's are present 1 When two or more R are present 1 Are the same or different from each other, or two adjacent R 1 Are connected with each other to form a substituted or unsubstituted ring; when two or more R's are present 5 When two or more R are present 5 Are the same or different from each other, or two adjacent R 5 Are connected with each other to form a substituted or unsubstituted ring;
n is 1 Selected from 1,2 or 3;
said R is 0 The same or different compounds are selected from any one of hydrogen, deuterium, tritium, C1-C6 alkyl and C6-C12 aryl; the R is 0 May be substituted by one or more substituents which may be the same or different and are selected from any one of deuterium, tritium, an alkyl group of C1 to C12, and an aryl group of C6 to C12;
n is 2 Selected from 0,1, 2,3 or 4; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other, or two adjacent R 0 Are connected with each other to form a substituted or unsubstituted alicyclic ring;
the above-mentioned
Figure BDA0003724720390000081
Containing at least one deuterium or tritium;
the Ra and the Rb are the same or different and are selected from any one of hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C12 aryl;
m is 1 Selected from 0,1, 2,3 or 4; when two or more Ra are present, the two or more Ra are the same or different from each other, or two adjacent Ra are linked to each other to form a substituted or unsubstituted benzene ring;
m is 2 Selected from 0,1, 2 or 3; when two or more Rb are present, the two or more Rb may be the same or different from each other, or two adjacent Rb may be linked to each other to form a substituted or unsubstituted benzene ring;
ar is 3 Any one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C18 aryl;
said L 1 、L 2 The same or different arylene groups are selected from single bond, substituted or unsubstituted arylene groups of C6-C18.
Preferably, the
Figure BDA0003724720390000082
Selected from any one of the structures shown below,
Figure BDA0003724720390000083
the R is 0 、R 6 Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl which are the same or different; the R is 0 May be substituted with one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl; the R is 6 May be substituted by one or more substituents which may be the same or different and are selected from deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, tert-butyl, trifluoromethyl, methyl, trifluoromethyl, or mixtures thereof,Any one of norbornyl and phenyl;
n is 3 The same or different is selected from 0,1, 2,3 or 4; n is 4 The same or different is selected from 0,1, 2 or 3; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other;
b is 1 The same or different is selected from 0,1 or 2; b is 2 The same or different is selected from 0,1, 2,3 or 4; b is 3 The same or different is selected from 0,1, 2,3, 4,5 or 6; b is 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; b is 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; b is 6 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; when two or more R's are present 6 When two or more R are present 6 The same or different from each other.
Preferably, the
Figure BDA0003724720390000091
Any one selected from the structures shown below,
Figure BDA0003724720390000092
the R is 0 、R 6 Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl which are the same or different; the R is 0 May be substituted with one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl; the R is 6 May be substituted with one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl;
n is 3 Same or differentAnd is selected from 0,1, 2,3 or 4; n is 4 The same or different is selected from 0,1, 2 or 3; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other;
b is 1 The same or different is selected from 0,1 or 2; b is 2 The same or different is selected from 0,1, 2,3 or 4; b is 3 The same or different is selected from 0,1, 2,3, 4,5 or 6; b is 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; b is 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; b is 6 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; when two or more R's are present 6 When two or more R are present 6 Are the same or different from each other;
said x 1 The same or different is selected from 1,2, 3 or 4; said x 2 The same or different is selected from 1,2, 3,4, 5 or 6; said x 3 The same or different is selected from 1,2, 3,4, 5, 6,7 or 8; said x 4 The same or different is selected from 1,2, 3,4, 5, 6,7,8, 9 or 10; said x 5 The same or different is selected from 1,2, 3,4, 5, 6,7,8, 9,10, 11 or 12; said x 6 The same or different is selected from 1,2, 3,4, 5, 6,7,8, 9,10, 11, 12, 13 or 14.
Preferably, the
Figure BDA0003724720390000101
At least two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, twenty-one, twenty-two, twenty-three, twenty-four, twenty-five deuterium or tritium.
Preferably, Ar is 1 、Ar 2 The same or different is selected from any one of the structures shown below,
Figure BDA0003724720390000102
Figure BDA0003724720390000111
the R is 1 、R 5 、R 7 Any one of hydrogen, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and terphenyl, which are the same or different; the R is 1 May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is 5 May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is 7 May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl;
a is a 1 The same or different is selected from 0,1, 2,3, 4 or 5; a is a 2 The same or different is selected from 0,1, 2 or 3; a is a 3 The same or different is selected from 0,1, 2,3 or 4; a is a 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; a is a 5 The same or different is selected from 0,1, 2,3, 4,5 or 6; a is a 6 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; a is a 7 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; when two or more R's are present 1 When two or more R are present 1 Are the same or different from each other; when two or more R's are present 5 When two or more R are present 5 Are the same or different from each other;
q is a number of 1 The same or different is selected from 0,1, 2,3, 4 or 5; q is a number of 2 The same or different is selected from 0,1, 2,3Or 4; q is a number of 3 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; q is a number of 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; q is a number of 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; q is a number of 6 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; q is a number of 7 The same or different is selected from 0,1, 2,3, 4,5 or 6; when two or more R's are present 7 When two or more R are present 7 The same or different from each other.
Preferably, the
Figure BDA0003724720390000121
Any one selected from the structures shown below,
Figure BDA0003724720390000122
the Ra, Rb and R 8 Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl and naphthyl; the Ra may be substituted by one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl; the Rb may be substituted by one or more substituents which may be the same or different and are any one selected from deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl; the R is 8 May be substituted with one or more substituents which may be the same or different, selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl;
m is 1 Selected from 0,1, 2,3 or 4; when two or more Ra s are present, the two or more Ra s may be the same as or different from each other, or two adjacent Ra s may be connected to each otherGrafting to form a substituted or unsubstituted benzene ring;
m is 2 Selected from 0,1, 2 or 3; when two or more Rb are present, the two or more Rb may be the same or different from each other, or two adjacent Rb may be linked to each other to form a substituted or unsubstituted benzene ring;
said p is 1 The same or different is selected from 0,1, 2,3 or 4; said p is 2 The same or different is selected from 0,1, 2,3, 4,5 or 6; said p is 3 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; said p is 4 Identical or different from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; said p is 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; said p is 6 The same or different is selected from 0,1, 2,3, 4 or 5; said p is 7 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; said p is 8 Identical or different from 0,1, 2,3, 4,5, 6,7,8 or 9; said p is 9 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10 or 11; said p is 10 The same or different is selected from 0,1, 2 or 3; when two or more R's are present 8 When two or more R are present 8 The same or different from each other.
Preferably, said L 1 、L 2 The same or different is selected from a single bond or any one of the structures shown below,
Figure BDA0003724720390000131
the R is 9 Any one of hydrogen, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl which are the same or different; the R is 9 May be substituted with one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
v is 1 The same or different ones are selected from 0,1,2.3 or 4; v is 2 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; when two or more R's are present 9 When two or more R are present 9 The same or different from each other.
Preferably, the material of the hole transport layer is selected from any one of the structures shown below,
Figure BDA0003724720390000132
Figure BDA0003724720390000141
Figure BDA0003724720390000151
Figure BDA0003724720390000161
Figure BDA0003724720390000171
Figure BDA0003724720390000191
Figure BDA0003724720390000201
Figure BDA0003724720390000211
Figure BDA0003724720390000221
Figure BDA0003724720390000231
Figure BDA0003724720390000241
Figure BDA0003724720390000251
Figure BDA0003724720390000261
Figure BDA0003724720390000271
Figure BDA0003724720390000281
Figure BDA0003724720390000291
Figure BDA0003724720390000301
Figure BDA0003724720390000311
Figure BDA0003724720390000321
Figure BDA0003724720390000331
Figure BDA0003724720390000341
Figure BDA0003724720390000351
preferably, the organic electroluminescent device of the present invention comprises: the light-emitting diode comprises an anode and a cathode which are oppositely arranged, a light-emitting layer positioned between the anode and the cathode, an electron blocking layer positioned between the light-emitting layer and the anode, a hole transport layer positioned between the electron blocking layer and the anode, and an electron transport region positioned between the light-emitting layer and the cathode.
The electron transport region comprises at least one of a hole blocking layer, an electron transport layer and an electron injection layer.
Preferably, the electron transport region of the present invention includes an electron transport layer.
Preferably, the electron transport region of the present invention includes an electron injection layer.
Preferably, the electron transport region of the present invention includes an electron transport layer and an electron injection layer.
Preferably, the electron transport region according to the present invention includes a hole blocking layer and an electron injection layer.
Preferably, the electron transport region according to the present invention includes a hole blocking layer and an electron transport layer.
Preferably, the electron transport region according to the present invention includes a hole blocking layer, an electron transport layer, and an electron injection layer.
Preferably, the organic electroluminescent device of the present invention further comprises: a hole injection layer located between the anode and the hole transport layer.
The structure of the organic electroluminescent device of the present invention having the above hole transport layer is further described with reference to fig. 1 and 2. As shown in fig. 1, the organic electroluminescent device according to the present invention may further include: a hole injection layer 6 between the anode 1 and the hole transport layer 5, a hole blocking layer 7 between the light emitting layer 3 and the cathode 2, an electron transport layer 8 between the hole blocking layer 7 and the cathode 2, and an electron injection layer 9 between the cathode 2 and the electron transport layer 8.
The present invention is not particularly limited to the thickness of each organic layer of the organic electroluminescent device, and may be any thickness commonly used in the art.
In the organic electroluminescent device according to the present invention, preferably, the thickness of the hole injection layer is 5nm to 20nm, the thickness of the hole transport layer is 80nm to 150nm, the thickness of the hole blocking layer is 5nm to 20nm, the thickness of the electron transport layer is 20nm to 50nm, and the thickness of the electron injection layer is 1nm to 10 nm.
The anode of the present invention preferably uses a high work function material (work function greater than 4.0eV) capable of promoting hole injection into other functional layers, and specific examples of the anode material that can be used in the present invention may include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, Indium Tin Oxide (ITO), Indium Zinc Oxide (IZO); combinations of metals and oxides, such as indium tin oxide-silver-indium tin oxide (ITO-Ag-ITO); and conductive polymers such as poly (3-methylthiophene), polypyrrole, polyaniline, poly [3,4- (ethylene-1, 2-dioxy) thiophene ] (PEDT), and the like, but not limited thereto.
The hole injection layer of the present invention preferably uses a material having a good hole accepting ability. Specific examples of the hole injection layer material that can be used in the present invention may include metal oxides such as silver oxide, vanadium oxide, tungsten oxide, copper oxide, titanium oxide, phthalocyanine compounds, benzidine compounds, phenazine compounds, and the like, such as copper phthalocyanine (CuPc), titanyl phthalocyanine, N '-diphenyl-N, N' -di- [4- (N, N-diphenylamine) phenyl ] benzidine (npnpnpb), N '-tetrakis (4-methoxyphenyl) benzidine (MeO-TPD), quinoxalino [2,3-a:2',3'-c ] phenazine (HATNA), 4',4 ″ -tris [ 2-naphthylphenylamino ] triphenylamine (2T-NATA), 2,3,6,7,10, 11-hexacyano-1, 4,5,8,9, 12-hexaazatriphenylene (HAT-CN), 4' -tris (N, N-diphenylamino) triphenylamine (TDATA), and the like, but is not limited thereto.
The electron blocking layer of the present invention preferably uses a material having an absolute value of a difference from the HOMO value of the hole transport layer of 0.07eV or more and 0.35eV or less, and specific examples may include triarylamine derivatives, spirofluorene derivatives, furan derivatives, and the like, such as TPD, NPB, N4, N4-bis ([1,1 '-biphenyl ] -4-yl) -N4' -phenyl N4'- [1,1':4', 1' -terphenyl ] -4-yl- [1,1' -biphenyl ] -4,4' -diamine, N- ([1,1' -diphenyl ] -4-yl) -N- (9, 9-dimethyl-9H-furan-2-yl) -9,9' -spirobifluorene-2-amine, N-bis ([1,1' -biphenyl ] -4-yl) -3' - (dibenzo [ b, d ] furan-4-yl) - [1,1' -biphenyl ] -4-amine, triamine compounds described in the present invention, and the like, but are not limited thereto. Preferably, the material of the electron blocking layer according to the present invention is selected from the structure shown in formula 2 below,
Figure BDA0003724720390000371
in the formula 2, Ar a 、Ar b The same or different structures are selected from any one of the structures shown in the chemical formulas I to IV,
Figure BDA0003724720390000372
ring B is selected from a substituted or unsubstituted spirocyclic structure;
the R is c -R g Any one of the same or different selected from hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C3-C12 alicyclic ring, C6-C18 aromatic ring fused ring group, and substituted or unsubstituted C6-C18 aryl;
m is a Selected from 0,1, 2 or 3; m is b Selected from 0,1, 2 or 3 or 4; when two or more R's are present c When two or more R are present c Are the same or different from each other, or are twoA neighboring R c Are connected with each other to form a substituted or unsubstituted ring; when two or more R's are present d When two or more R are present d Are the same or different from each other, or two adjacent R d Are connected with each other to form a substituted or unsubstituted ring;
ar is c Selected from any one of the structures shown below,
Figure BDA0003724720390000373
the R is h Any one of the same or different selected from hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C3-C12 alicyclic ring, C6-C18 aromatic ring fused ring group, and substituted or unsubstituted C6-C18 aryl;
n is a The same or different is selected from 0,1, 2,3, 4 or 5; n is b The same or different is selected from 0,1, 2,3 or 4; n is c The same or different is selected from 0,1, 2 or 3; when two or more R's are present h When two or more R are present h Are the same or different from each other, or adjacent R h Are connected with each other to form a substituted or unsubstituted ring;
L a ~L c the same or different arylenes are selected from single bond, substituted or unsubstituted C6-C18;
the above-mentioned
Figure BDA0003724720390000374
Containing at least one deuterium or tritium.
Preferably, said Ar a 、Ar b The same or different is selected from any one of the structures shown below,
Figure BDA0003724720390000381
Figure BDA0003724720390000391
the R is c 、R d 、R i Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, benzocyclopropyl, benzocyclobutenyl, benzocyclopentyl, and benzocyclohexyl, which may be the same or different; the R is c May be substituted with one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl; the R is d May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is i May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl;
m is a The same or different is selected from 0,1, 2 or 3; m is b The same or different is selected from 0,1, 2,3 or 4; m is c The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; m is d The same or different is selected from 0,1, 2,3, 4,5 or 6; m is e The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; m is f The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; m is g The same or different is selected from 0,1, 2,3, 4 or 5; when two or more R's are present c When two or more R are present c Are the same or different from each other; when two or more R's are present d When two or more R are present d Are the same or different from each other;
v is a The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; v is b The same or different is selected from 0,1, 2,3, 4,5, 6,7,89 or 10; v is c The same or different is selected from 0,1, 2,3, 4 or 5; v is d The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10 or 11; v is e The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; v is f The same or different is selected from 0,1, 2,3 or 4; v is g The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; v is h The same or different is selected from 0,1, 2,3, 4,5 or 6; v is i The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; when two or more R's are present i When two or more R are present i The same or different from each other.
Preferably, Ar is c Selected from any one of the structures shown below,
Figure BDA0003724720390000401
Figure BDA0003724720390000411
the R is h Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl;
the R is h May be substituted with one or more substituents selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
n is a The same or different is selected from 0,1, 2,3, 4 or 5; n is b The same or different is selected from 0,1, 2,3 or 4; n is c The same or different is selected from 0,1, 2 or 3; n is d The same or different is selected from 0,1 or 2; n is e The same or different are selected from 0,1.2, 3,4, 5 or 6; n is f The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; n is g The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; when two or more R's are present h When two or more R are present h The same or different from each other.
Preferably, Ar is c Selected from any one of the structures shown below,
Figure BDA0003724720390000421
Figure BDA0003724720390000431
said y 1 The same or different is selected from 0,1, 2,3, 4 or 5; said y 2 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; said y 3 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; said y 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10 or 11; said y 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11, 12 or 13; said y 6 The same or different is selected from 0,1, 2,3 or 4;
the R is h Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl;
the R is h May be substituted with one or more substituents selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
n is a The same or different is selected from 0,1, 2,3, 4 or 5; n is b The same or different is selected from 0,1, 2,3 or 4; the above-mentionedn c The same or different is selected from 0,1, 2 or 3; n is d The same or different is selected from 0,1 or 2; n is e The same or different is selected from 0,1, 2,3, 4,5 or 6; n is f The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; n is g The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; when two or more R's are present h When two or more R are present h The same or different from each other.
Preferably, said L a ~L c The same or different is selected from a single bond or any one of the structures shown below,
Figure BDA0003724720390000432
the R is k Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, benzocyclopropyl, benzocyclobutenyl, benzocyclopentyl, and benzocyclohexyl, which may be the same or different; the R is 9 May be substituted with one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
k is the same as 1 The same or different is selected from 0,1, 2,3 or 4; k is the same as 2 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; when two or more R's are present k When two or more R are present k Are the same or different from each other, or two adjacent R k Are linked to each other to form a substituted or unsubstituted ring.
Preferably, the
Figure BDA0003724720390000433
At least comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen and fourteenFifteen, sixteen, seventeen, eighteen, nineteen, twenty-one, twenty-two, twenty-three, twenty-four, twenty-five deuterium or tritium.
Preferably, the material of the electron blocking layer according to the present invention is selected from any one of the following structures,
Figure BDA0003724720390000441
Figure BDA0003724720390000451
Figure BDA0003724720390000461
Figure BDA0003724720390000471
Figure BDA0003724720390000481
Figure BDA0003724720390000491
Figure BDA0003724720390000501
Figure BDA0003724720390000511
Figure BDA0003724720390000521
Figure BDA0003724720390000531
Figure BDA0003724720390000541
Figure BDA0003724720390000551
the light emitting layer of the present invention is a layer in which holes and electrons meet to form excitons, and the color of light emitted from the organic electroluminescent device may be changed depending on the material constituting the light emitting layer. The light emitting layer includes a host material and a dopant material, and the mixing ratio thereof may be appropriately adjusted within a range known in the art. The light emitting layer may include 70 to 99.9 parts by weight of a host material and 0.1 to 30 parts by weight of a dopant material, based on the entire weight of the light emitting layer. Preferably, in the case where the light emitting layer is blue fluorescent, green fluorescent, or red fluorescent, the light emitting layer may include 80 to 99.9 parts by weight of the host material and 0.1 to 20 parts by weight of the dopant material. Preferably, in the case where the light emitting layer is blue fluorescent, green fluorescent, or red phosphorescent, 70 to 99 parts by weight of the host material and 1 to 30 parts by weight of the dopant material may be included. The host material included in the light-emitting layer of the present invention may be any known host material in the art, and may be an alkali metal complex compound, an alkaline earth metal complex compound, a condensed aromatic ring derivative, or the like. Specific examples of the host material usable in the present invention may include one or a combination of more than one of an aluminum complex, a beryllium complex, an anthracene derivative, a pyrene derivative, a triphenylene derivative, a carbazole derivative, a dibenzofuran derivative, and a dibenzothiophene derivative, such as 4,4 '-bis (9-Carbazole) Biphenyl (CBP), 9, 10-bis (2-naphthyl) Anthracene (ADN), 4-bis (9-carbazolyl) biphenyl (CPB), 9' - (1, 3-phenyl) bis-9H-carbazole (mCP), 4',4 ″ -tris (carbazol-9-yl) triphenylamine (TCTA), 9, 10-bis (1-naphthyl) anthracene (. alpha. -ADN), N' -Bis- (1-naphthyl) -N, N '-diphenyl- [1,1':4',1 ": 4", 1' "-quaterphenyl]-4,4' -diamino (4PNPB), 1,3, 5-tris (9-carbazolyl) benzene (TCP), and the like, but is not limited thereto. The doping material included in the light emitting layer according to the present invention may be a known doping material, and may be a red doping material, a green doping material, and a blue doping material. The red doped material can be one or more of octaethylporphyrin platinum (II) (PtOEP), tris (2-phenylisoquinoline) iridium (Ir (piq)3), bis (2- (2 '-benzothienyl) -pyridine-N, C3') (acetylacetone) iridium) (Btp2Ir (acac)) in combination; the green dopant material may be tris (2-phenylpyridine) iridium (Ir (ppy)3), bis (2-phenylpyridine) (acetylacetonato) iridium (III) (Ir (ppy) 2 (acac)), tris (2- (4-tolyl) phenylpyridine) iridium (Ir (mppy)3), 10- (2-benzothiazolyl) -1,1,7, 7-tetramethyl-2, 3,6,7, -tetrahydro-1H, 5H,11H- [ 1H ] 1]Benzopyrano [6,7,8-ij]-one or a combination of more than one of quinolizin-11-ones (C545T); the blue doping material can be one or more of bis [3, 5-difluoro-2- (2-pyridyl) phenyl (picolinyl) iridium (III) (F2Irpic), 4' -bis (2,2' -diphenylethylene-1-yl) biphenyl (DPVBi), 4' -bis (4-diphenylaminostyryl) biphenyl (DPAVBi) and 2,5,8, 11-tetra-tert-butylperylene (TBPe).
The light-emitting layer of the present invention may be a single layer made of one substance, a single layer made of a plurality of substances different from each other, or a multilayer made of two or more layers each made of a different substance from each other. When the light-emitting layer is a plurality of layers, the organic electroluminescent element can emit light of a plurality of colors.
The organic electroluminescent device according to the present invention may have a plurality of light emitting layer stacks including at least one of the light emitting layers. The plurality of light emitting layers included in the light emitting layer stack may each include a light emitting layer emitting light of a different color from each other or a light emitting layer emitting light of the same color. That is, the emission color may vary depending on the substance constituting the light emitting layer. For example, the plurality of light emitting layer stacks may include a substance emitting light of blue, green, red, yellow, white, or the like, and may be formed using a phosphorescent or fluorescent substance. At this time, the colors emitted by the light emitting layers may be in a complementary color relationship with each other. In addition, the color may be selected according to a combination of colors that can emit white light.
The hole blocking layer according to the present invention preferably uses a material having a strong hole blocking ability and an appropriate HOMO/LUMO energy level. Specific examples of the hole-blocking layer material that can be used in the present invention may include imidazoles, triazoles, phenanthroline derivatives, and the like, such as 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1, 2, 4-Triazole (TAZ), bis (2-methyl-8-hydroxyquinoline) (4-phenylphenol) aluminum (III) (BAlq), and the like, but are not limited thereto.
The electron transport layer of the present invention preferably uses a material having a strong electron-withdrawing ability and a low HOMO and LUMO energy level, and specific examples of the electron transport layer material that can be used in the present invention may include imidazoles, triazoles, phenanthroline derivatives, quinolines, and the like, such as 2,9- (dimethyl) -4, 7-biphenyl-1, 10-phenanthroline (BCP), 1,3, 5-tris [ (3-pyridyl) -phenyl ] benzene (TmPyPB), 4' -bis (4, 6-diphenyl-1, 3, 5-triazinyl) biphenyl (BTB), 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 3- (biphenyl-4-yl) -5- (4-tert-butylphenyl) -4-phenyl-4H-1, 2, 4-Triazole (TAZ), 2- (naphthalen-2-yl) -4,7- (diphenyl) -1, 10-phenanthroline (HNBphen), 8-hydroxyquinoline-Lithium (LiQ), etc., but are not limited thereto.
The electron injection layer according to the present invention preferably uses a material having a small potential barrier from an adjacent organic transport material and having an effect of injecting electrons from the cathode, and specific examples of the electron injection layer material that can be used in the present invention may include alkali metal salts (such as LiF, CsF), alkaline earth metal salts (such as MgF) 2 ) Metal oxides (e.g. Al) 2 O 3 、MoO 3 ) But is not limited thereto.
The cathode according to the present invention preferably uses a low work function material capable of facilitating electron injection into the organic layer, and specific examples of the cathode material that can be used in the present invention may include metals such as aluminum, magnesium, silver, indium, tin, titanium, and the like, and alloys thereof; multilayer metallic materials, e.g. LiF/Al, Mg/Ag, Li/Al, LiO 2 /Al、BaF 2 Al, etc., but are not limited thereto.
The organic electroluminescent device according to the present invention may further include a capping layer, and the capping layer according to the present invention preferably uses a material capable of improving optical coupling, and specific examples of the capping layer material that may be used in the present invention may include, but are not limited to, arylamine derivatives, carbazole derivatives, benzimidazole derivatives, triazole derivatives, lithium fluoride, and the like.
The organic electroluminescent device according to the present invention may further include a substrate, and the substrate according to the present invention may preferably use a material that does not change when forming an electrode and other functional layers, and specific examples of the substrate material that may be used in the present invention may include glass, quartz, plastic, polymer film, silicon, and the like, but are not limited thereto. The substrate may be retained in a light-emitting device or an electronic apparatus using the organic electroluminescent device of the present invention, or may not be retained in a final product and may function as a support only in a manufacturing process of the organic electroluminescent device.
However, the structure of the organic electroluminescent device according to the present invention is not limited thereto. The organic electroluminescent device can be selected and combined according to the parameter requirements of the device and the characteristics of materials, part of organic layers can be added or omitted, and the organic layers with the same function can be made into a laminated structure with more than two layers.
The light emitting type of the organic electroluminescent device can be a top emitting device or a bottom emitting device, and the difference between the light emitting type and the bottom emitting device is that the light emitting direction of the device is emitted through the substrate or light emitted in a direction deviating from the substrate. For bottom-emitting devices, the light-emitting direction of the device is through the substrate emission; for top-emitting devices, the light-emitting direction of the device is the direction away from the substrate.
The structure of the organic electroluminescent device can be a positive structure or an inverted structure, and the difference between the positive structure and the inverted structure lies in that the manufacturing sequence of organic layers is different, and specifically comprises the following steps: the positive structure is formed by sequentially forming a cathode, an electron injection layer, an electron transport layer, a hole blocking layer, a light emitting layer, an electron blocking layer, a hole transport layer, a hole injection layer and an anode on a substrate, and the negative structure is formed by sequentially forming an anode, a hole injection layer, a hole transport layer, an electron blocking layer, a light emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer and a cathode on a substrate.
The organic electroluminescent device of the present invention may be any one of a vacuum evaporation method, a spin coating method, a vapor deposition method, a blade coating method, a laser thermal transfer method, an electrospray coating method, a slit coating method, and a dip coating method.
The organic electroluminescent device can be widely applied to the fields of panel display, lighting sources, flexible OLEDs, electronic paper, organic solar cells, organic photoreceptors or organic thin film transistors, signs, signal lamps and the like.
The invention is explained in more detail by the following examples, without wishing to restrict the invention accordingly. Based on this description, one of ordinary skill in the art will be able to practice the invention and prepare other compounds and devices according to the invention within the full scope of the disclosure without undue inventive effort.
Preparation and characterization of the Compounds
The method for preparing the structure represented by formula 1 of the present invention is not particularly limited, and conventional methods well known to those skilled in the art may be employed.
For example, carbon-nitrogen coupling reaction, carbon-carbon coupling reaction, etc., the structure represented by formula 1 of the present invention can be prepared by the following synthetic route.
Figure BDA0003724720390000581
The method for preparing the structure represented by formula 2 of the present invention is not particularly limited, and conventional methods well known to those skilled in the art may be used. For example, carbon-nitrogen coupling reaction, carbon-carbon coupling reaction, etc., the structure represented by formula 2 of the present invention can be prepared by the following synthetic route.
Figure BDA0003724720390000582
Said X a Identical or different from halogen, for example Cl, Br, I.
Description of raw materials, reagents and characterization equipment:
the present invention is not particularly limited to the starting materials and sources of reagents used in the following examples, and they may be commercially available products or prepared by methods known to those skilled in the art. The raw materials and reagents used in the invention are all pure reagents.
The mass spectrum uses British Watts G2-Si quadrupole rod series time-of-flight high resolution mass spectrometer, chloroform is used as solvent;
the element analysis uses a Vario EL cube type organic element analyzer of Germany Elementar company, and the mass of a sample is 5-10 mg;
synthesis example 1 Synthesis of intermediate 3-A
Figure BDA0003724720390000591
Under nitrogen protection, 3-a (80.00mmol, 22.97g), 3-b (80.00mmol, 22.95g), palladium tetrakistriphenylphosphine (1.60mmol, 1.85g), potassium carbonate (156.00mmol, 21.56g), 450mL of toluene, 150mL of ethanol, and 150mL of water were added to a reaction flask, and the mixture was stirred, and the above system was heated under reflux for 3.5 h. After completion of the reaction, the reaction mixture was cooled to room temperature, water was added, the mixture was extracted with dichloromethane, the organic layer was dried over anhydrous magnesium sulfate, filtered, and the solvent was removed, and the residue was purified by filtration, washed with toluene/ethanol ═ 4: 1 recrystallisation to give intermediate 3-a (26.07g, 81% yield); the purity of the solid was 99.75% by HPLC. Mass spectrum m/z: 401.0723 (theoretical value: 401.0717).
Synthesis example 2 Synthesis of intermediate 75-A
Figure BDA0003724720390000592
The same procedure was repeated except for replacing 3-a in Synthesis example 1 with an equimolar amount of 75-a and 3-b with an equimolar amount of 75-b to give intermediate 75-c (22.48g, yield 80%) having a purity of 99.63% by HPLC. Mass spectrum m/z: 281.0923 (theoretical value: 281.0909).
Intermediate 75-c (60mmol, 16.86g) was dissolved in 600ml of NMP, and then compound 75-d (78mmol, 15.37g), sodium sulfate (60mmol, 8.4g), potassium carbonate (60mmol, 8.4g) and copper (18mmol, 1.2g) were added and reacted at 200 ℃ for 12 hours. Cooling to room temperature, removing the solvent by distillation under reduced pressure, washing with distilled water, extracting with dichloromethane, drying the organic phase with anhydrous magnesium sulfate, and then removing the solvent by distillation under reduced pressure, the solvent was purified by distillation under reduced pressure, and the solvent was purified by toluene/ethanol ═ 5: 1 recrystallisation for purification gave intermediate 75-a (17.87g, 75% yield) with a purity of 99.60% by HPLC. Mass spectrum m/z: 397.1542 (theoretical value: 397.1535).
Synthesis example 3 Synthesis of intermediate 107-A
Figure BDA0003724720390000593
The same procedure was repeated except for replacing 3-a in Synthesis example 1 with an equimolar amount of 107-e and replacing 3-b with an equimolar amount of 107-f to obtain intermediate 107-d (17.29g, yield 78%) having a purity of 99.53% by HPLC. Mass spectrum m/z: 277.0519 (theoretical value: 277.0514).
The 75-d in Synthesis example 2 was replaced with an equimolar amount of 107-d and the other steps were the same to give intermediate 107-A (21.52g, yield 75%) having a purity of 99.41% by HPLC. Mass spectrum m/z: 478.2154 (theoretical value: 478.2162).
Synthesis example 4 Synthesis of intermediate 191-A
Figure BDA0003724720390000601
The 75-d in Synthesis example 2 was replaced with an equimolar amount of 191-d and the other steps were the same to give intermediate 191-A (22.69g, 77% yield) having a solid purity of 99.69% by HPLC. Mass spectrum m/z: 491.2322 (theoretical value: 491.2318).
The following intermediates were prepared according to the preparation method of synthesis example 1, with the following raw materials and intermediates:
Figure BDA0003724720390000602
Figure BDA0003724720390000611
[ Synthesis example 5] Synthesis of intermediate 3-B
Figure BDA0003724720390000612
Toluene (150mL), 3-A (40.00mmol, 16.04g), 3-g (40.00mmol, 10.14g), palladium acetate (0.60mmol, 0.13g), sodium tert-butoxide (80.00mmol, 7.69g) and tri-tert-butylphosphine (2.40mmol, 0.49g) were added to a reaction flask in this order under nitrogen protection, and the mixture was dissolved by stirring and reacted for 3 hours under reflux. After completion of the reaction, the reaction solution was cooled to room temperature, water was added, extraction was performed with dichloromethane, the organic phase was dried over anhydrous magnesium sulfate, filtered, and the solvent was removed under reduced pressure, and the residue was purified by filtration with toluene/methanol ═ 10: 1 recrystallization purification gave 3-B (24.12g, 82% yield) with a purity of 99.59% by HPLC. Mass spectrum m/z: 490.2355 (theoretical value: 490.2347)
The following intermediates were prepared according to the preparation method of synthesis example 5, with the following raw materials and intermediates:
Figure BDA0003724720390000613
Figure BDA0003724720390000621
Figure BDA0003724720390000631
Figure BDA0003724720390000641
synthesis example 6 Synthesis of Compounds 1 to 3
Figure BDA0003724720390000642
Toluene (150mL), 3-B (20.00mmol, 14.37g), 3-h (26.00mmol, 8.16g), tris-dibenzylideneacetone dipalladium (0.20mmol, 0.19g), sodium tert-butoxide (40.00mmol, 3.85g) and tri-tert-butylphosphine (1.60mmol, 0.33g) were added to a reaction flask in this order under nitrogen protection, and the mixture was dissolved by stirring and refluxed for 6.5 hours. After completion of the reaction, the reaction solution was cooled to room temperature, water was added, extraction was performed with chloroform, the organic phase was dried over anhydrous magnesium sulfate, filtered, the solvent was removed under reduced pressure, and recrystallization was performed with toluene to obtain compound 1-3(9.40g, yield 83%) with a solid purity of 99.95% by HPLC. Mass spectrum m/z: 566.2668 (theoretical value: 566.2660). Theoretical element content (%) C 42 H 26 D 4 N 2 : c, 89.01; h, 6.05; and N, 4.94. Measured elemental content (%): c, 89.03; h, 6.02; and N, 4.95.
The following compounds were prepared according to the preparation method of synthesis example 6, with corresponding substitution of the intermediate and starting materials:
Figure BDA0003724720390000643
Figure BDA0003724720390000651
Figure BDA0003724720390000661
Figure BDA0003724720390000671
synthetic example 7: preparation of intermediate c-2-107
Figure BDA0003724720390000672
Under the protection of nitrogen, adding n into the reaction bottle in sequence 1 -2-107(13.89g,60mmol),n 2 -2-107(15.00g, 63mmol), potassium carbonate (12.44g, 90mmol), Pd (PPh) 3 ) 4 (0.69g, 0.60mmol), 400mL of a toluene/ethanol/water (3:1:1) mixed solvent was added, the mixture was stirred, and the above reactant system was heated under reflux for 8 hours. After the reaction is finished, cooling to room temperature, adding methylbenzene to separate phases, washing the methylbenzene phase with distilled water for three times, drying with anhydrous magnesium sulfate, filtering, distilling and concentrating the filtrate under reduced pressure, cooling and crystallizing, performing suction filtration, recrystallizing the obtained solid with toluene to obtain an intermediate c-2-107(16.14g, the yield is 78%), and detecting the purity of the solid by HPLC (high performance liquid chromatography) to be not less than 99.37%. Mass spectrum m/z: 344.1349 (theoretical value: 344.1332).
Synthesis example 8: preparation of intermediate c-2-201
Figure BDA0003724720390000673
Intermediate n 2 -2-201 preparation:
under the protection of nitrogen, adding n into the reaction bottle in sequence 3 -2-201(24.95g, 90.00mmol), pinacol diboron (24.12g, 95.00mmol), Pd (dppf) Cl 2 (0.66g, 0.90mmol), KOAc (15.70g, 160.00mmol), adding 500mL DMF, refluxing, heating, reacting for 4 hours, adding distilled water after reaction, extracting with dichloromethane, washing the organic phase with distilled water for three times, standing, separating, collecting the organic phase, drying with anhydrous magnesium sulfate, filtering, distilling and concentrating the filtrate under reduced pressure, cooling, crystallizing, filtering, and adding methyl acetate to the obtained solidBenzene is recrystallized to obtain an intermediate n 2 -2-201(22.18g, yield 76%); HPLC purity is more than or equal to 98.68 percent. Mass spectrum m/z: 324.2186 (theoretical value: 324.2199).
Preparation of intermediate c-2-201:
according to the preparation method of Synthesis example 1, n is added in equimolar amounts 1 -2-107、n 2 -2 to 107 are each replaced by equimolar amounts of n 1 -2-201、n 2 2-201 to obtain intermediate c-2-201(13.90g, 75%) with HPLC purity ≧ 99.58%. Mass spectrum m/z: 308.1283 (theoretical value: 308.1270).
Synthetic example 9: preparation of intermediate c-2-245
Figure BDA0003724720390000681
According to the preparation method of Synthesis example 7, n is added in equimolar amounts 1 -2-107、n 2 -2 to 107 are each replaced by equimolar amounts of n 1 -2-245、n 2 2-245 to obtain intermediate c-2-245(16.03g) with an HPLC purity of 99.43% or higher. Mass spectrum m/z: 360.1632 (theoretical value: 360.1645).
Synthetic example 10: intermediate c 1 Preparation of (E) -2-289
Figure BDA0003724720390000682
According to the preparation method of Synthesis example 7, n is added in equimolar amounts 1 -2-107、n 2 -2 to 107 are each replaced by equimolar amounts of n 1 -2-107、n 2 -2-289 to give intermediate c 1 -2-289(11.08g), HPLC purity ≧ 99.58%. Mass spectrum m/z: 233.1003 (theoretical value: 233.1020).
Synthetic example 11: preparation of Compounds 2-6
Figure BDA0003724720390000683
Preparation of intermediate M-2-6:
adding m into the reaction bottle in sequence under the protection of nitrogen 1 -2-6(28.81g, 150.00mmol), pinacol diboron (40.12g, 158.00mmol), Pd (dppf) Cl 2 (1.10g, 1.50mmol) and KOAc (27.48g, 280.00mmol), 600mL of DMF was added, the mixture was stirred, and the reaction was heated under reflux for 3 hours. After the reaction is finished, cooling to room temperature, adding distilled water, extracting with dichloromethane, washing an organic phase with distilled water for three times, standing, separating liquid, collecting the organic phase, drying with anhydrous magnesium sulfate, filtering, distilling and concentrating the filtrate under reduced pressure, cooling, crystallizing, filtering, and recrystallizing the obtained solid with toluene to obtain an intermediate M-2-6(27.78g, yield 83%); HPLC purity is more than or equal to 98.72 percent. Mass spectrum m/z: 223.1666 (theoretical value: 223.1682).
Preparation of intermediate b-2-6:
under the protection of nitrogen, M-2-6(26.77g, 120mmol) and M are added into a reaction bottle in sequence 2 -2-6(40.82g, 132mmol), potassium carbonate (30.41g, 220mmol), Pd (PPh) 3 ) 4 (1.39g, 1.20mmol), 500mL of a toluene/ethanol/water (3:1:1) mixed solvent was added, the mixture was stirred, and the reaction was refluxed for 10 hours. After the reaction is finished, cooling to room temperature, adding methylbenzene to separate phases, washing the methylbenzene phase with distilled water for three times, standing and separating, collecting an organic phase, drying with anhydrous magnesium sulfate, filtering, distilling and concentrating the filtrate under reduced pressure, cooling and crystallizing, filtering, and recrystallizing the obtained solid with toluene to obtain an intermediate b-2-6(31.96g, yield 78%). The HPLC purity is more than or equal to 99.71 percent. Mass spectrum m/z: 341.2066 (theoretical value: 341.2082).
Preparation of intermediate I-2-6:
under the protection of nitrogen, a-2-6(25.70g, 80mmol), b-2-6(27.32g, 80mmol), sodium tert-butoxide (15.38g, 160mmol), Pd (dppf) Cl were added to the reaction flask in this order 2 (0.59g, 0.8mmol), and 400ml of toluene was added thereto to dissolve it, followed by heating and refluxing for 4.5 hours. After the reaction is finished, cooling to room temperature, adding distilled water, extracting with dichloromethane, washing an organic phase with distilled water for three times, standing and separating liquid, collecting the organic phase, drying with anhydrous magnesium sulfate, filtering, distilling and concentrating the filtrate under reduced pressure, cooling and crystallizing, filtering, recrystallizing the obtained solid with ethyl acetate to obtain an intermediate I-2-6 (I-2-6)34.85g, the yield is 77%), and the purity of the solid is ≧ 99.55% by HPLC. Mass spectrum m/z: 565.2720 (theoretical value: 565.2708).
Preparation of Compounds 2-6:
under the protection of nitrogen, sequentially adding the intermediates I-2-6(22.63g, 40mmol), c-2-6(15.89g, 40mmol) and Pd into a reaction bottle 2 (dba) 3 (0.37g, 0.40mmol), BINAP (0.50g, 0.80mmol) and sodium tert-butoxide (6.73g, 70mmol), 300mL of toluene is added, the mixture is stirred and dissolved, heating reflux reaction is carried out for 24 hours, after the reaction is finished, the mixture is cooled to room temperature, distilled water is added, dichloromethane is used for extraction, the organic phase is washed with distilled water for three times, standing and liquid separation are carried out, the organic phase is collected and dried with anhydrous magnesium sulfate, filtration is carried out, the filtrate is concentrated by reduced pressure distillation, crystallization is carried out by cooling, suction filtration is carried out, the obtained solid is recrystallized by toluene, and the compound 2-6(26.46g, the yield is 75%) is obtained, and the purity of the solid is not less than 99.92% by HPLC (HPLC). Mass spectrum m/z: 881.3949 (theoretical value: 881.3960). Theoretical element content (%) C 68 H 43 D 4 N: c, 92.59; h, 5.83; n, 1.59. Measured elemental content (%): c, 92.61; h, 5.79; n, 1.62.
Synthetic example 12: preparation of Compounds 2-31
Figure BDA0003724720390000691
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-31, b-2-31 and c-2-31, respectively, to obtain compound 2-31(26.82g) with an HPLC purity of 99.91% or higher. Mass spectrum m/z: 881.3975 (theoretical value: 881.3960). Theoretical element content (%) C 68 H 43 D 4 N: c, 92.59; h, 5.83; n, 1.59. Measured elemental content (%): c, 92.62; h, 5.79; n, 1.61.
Synthetic example 13: preparation of Compounds 2-44
Figure BDA0003724720390000692
According to the preparation method of Synthesis example 11Equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar c-2-31, b-2-44 and c-2-31, respectively, to give compound 2-44(25.55g) with an HPLC purity ≧ 99.95%. Mass spectrum m/z: 862.4254 (theoretical value: 862.4242). Theoretical element content (%) C 66 H 34 D 11 N: c, 91.84; h, 6.54; n, 1.62. Measured elemental content (%): c, 91.79; h, 6.56; n, 1.59.
Synthesis example 14: preparation of Compounds 2-69
Figure BDA0003724720390000701
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-69, b-2-69 and c-2-69, respectively, to obtain compound 2-69(21.24g) with an HPLC purity of 99.93% or higher. Mass spectrum m/z: 680.3223 (theoretical value: 680.3240). Theoretical element content (%) C 52 H 32 D 5 N: c, 91.73; h, 6.22; and N, 2.06. Measured elemental content (%): c, 91.69; h, 6.08; and N, 2.10.
Synthetic example 15: preparation of Compounds 2-80
Figure BDA0003724720390000702
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-69, b-2-80 and c-2-69, respectively, to obtain compound 2-80(21.05g) with an HPLC purity of ≧ 99.97%. Mass spectrum m/z: 720.3570 (theoretical value: 720.3553). Theoretical element content (%) C 55 H 36 D 5 N: c, 91.63; h, 6.43; n, 1.94. Measured elemental content (%): c, 91.59; h, 6.38; and N, 1.97.
Synthetic example 16: preparation of Compounds 2-107
Figure BDA0003724720390000703
Preparation according to Synthesis example 11The method comprises the steps of replacing equimolar a-2-6, equimolar b-2-6 and equimolar c-2-6 with equimolar c-2-69, equimolar b-2-107 and equimolar c-2-107 respectively to obtain a compound 2-107(26.76g), wherein the HPLC purity is not less than 99.93%. Mass spectrum m/z: 928.4851 (theoretical value: 928.4836). Theoretical element content (%) C 71 H 56 D 3 N: c, 91.77; h, 6.72; n, 1.51. Measured elemental content (%): c, 91.80; h, 6.68; and N, 1.47.
Synthetic example 17: preparation of Compounds 2 to 123
Figure BDA0003724720390000704
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-123, b-2-123 and c-2-123, respectively, to obtain compound 2-123(25.73g) with an HPLC purity of 99.96% or more. Mass spectrum m/z: 868.4821 (theoretical value: 868.4805). Theoretical element content (%) C 66 H 52 D 5 N: c, 91.20; h, 7.19; n, 1.61. Measured elemental content (%): c, 91.18; h, 7.21; n, 1.57.
Synthetic example 18: preparation of Compounds 2-167
Figure BDA0003724720390000711
According to the preparation method of synthetic example 11, equimolar a-2-6 and equimolar b-2-6 were replaced with equimolar a-2-69 and equimolar b-2-167, respectively, to obtain compound 2-167(20.96g), which had an HPLC purity of ≧ 99.92%. Mass spectrum m/z: 737.3946 (theoretical value: 737.3960). Theoretical element content (%) C 56 H 43 D 4 N: c, 91.14; h, 6.96; and N, 1.90. Measured elemental content (%): c, 91.11; h, 6.93; n, 1.88.
Synthetic example 19: preparation of Compounds 2-183
Figure BDA0003724720390000712
Preparation according to Synthesis example 11The method comprises replacing equimolar a-2-6 and equimolar b-2-6 with equimolar a-2-183 and equimolar b-2-183 respectively to obtain compound 2-183(22.85g), wherein the HPLC purity is not less than 99.94%. Mass spectrum m/z: 815.4410 (theoretical value: 815.4429). Theoretical element content (%) C 62 H 49 D 4 N: c, 91.24; h, 7.04; n, 1.72. Measured elemental content (%): c, 91.19; h, 7.07; n, 1.68.
Synthetic example 20: preparation of Compounds 2-201
Figure BDA0003724720390000713
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-201, b-2-201 and c-2-201, respectively, to obtain compound 2-201(21.81g) with an HPLC purity of 99.91% or more. Mass spectrum m/z: 789.4231 (theoretical value: 789.4211). Theoretical element content (%) C 60 H 39 D 8 N: c, 91.21; h, 7.01; n, 1.77. Measured elemental content (%): c, 91.18; h, 7.04; n, 1.69.
Synthetic example 21: preparation of Compounds 2-245
Figure BDA0003724720390000714
According to the preparation method of Synthesis example 11, equimolar of a-2-6, b-2-6 and c-2-6 were each replaced with equimolar of n 3 2-201, b-2-245 and c-2-245 to obtain a compound 2-245(18.24g) with an HPLC purity ≧ 99.93%. Mass spectrum m/z: 690.4009 (theoretical value: 690.4022). Theoretical element content (%) C 52 H 42 D 5 N: c, 90.39; h, 7.58; and N, 2.03. Measured elemental content (%): c, 90.42; h, 7.61; and N, 2.06.
Synthetic example 22: preparation of Compounds 2-276
Figure BDA0003724720390000721
According to the synthetic examples11 by replacing equimolar a-2-6, b-2-6 and c-2-6 with equimolar a-2-276, b-2-276 and c-2-276 respectively, compound 2-276(17.93g) was obtained with an HPLC purity of 99.98% or higher. Mass spectrum m/z: 574.3378 (theoretical value: 574.3396). Theoretical element content (%) C 43 H 34 D 5 N: c, 89.85; h, 7.71; n, 2.44. Measured elemental content (%): c, 89.88; h, 7.67; and N, 2.39.
Synthetic example 23: preparation of Compounds 2-289
Figure BDA0003724720390000722
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-289, b-2-289 and c-2-289, respectively, to obtain compound 2-289(23.93g) with an HPLC purity of 99.94% or more. Mass spectrum m/z: 866.4633 (theoretical value: 866.4648). Theoretical element content (%) C 66 H 50 D 5 N: c, 91.41; h, 6.97; n, 1.62. Measured elemental content (%): c, 91.39; h, 6.94; n, 1.58.
Synthetic example 24: preparation of Compounds 2-300
Figure BDA0003724720390000723
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-300, b-2-300 and c-2-300, respectively, to obtain compound 2-300(20.65g) with HPLC purity ≧ 99.96%. Mass spectrum m/z: 758.4634 (theoretical value: 758.4617). Theoretical element content (%) C 57 H 46 D 7 N: c, 90.19; h, 7.97; n, 1.85. Measured elemental content (%): c, 90.21; h, 7.95; and N, 1.90.
Synthetic example 25: preparation of Compounds 2 to 308
Figure BDA0003724720390000724
According to the production method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-308, b-2-308 and c-2-276, respectively, to obtain compound 2-308(22.58g) with an HPLC purity of 99.90% or higher. Mass spectrum m/z: 817.4505 (theoretical value: 817.4524). Theoretical element content (%) C 62 H 43 D 8 N: c, 91.02; h, 7.27; n, 1.71. Measured elemental content (%): c, 91.05; h, 7.30; n, 1.68.
Synthetic example 26: preparation of Compounds 2-337
Figure BDA0003724720390000731
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-69, b-2-337 and c-2-6, respectively, to obtain compound 2-337(24.31g) with an HPLC purity ≧ 99.94%. Mass spectrum m/z: 843.3821 (theoretical value: 843.3803). Theoretical element content (%) C 65 H 41 D 4 N: c, 92.49; h, 5.85; n, 1.66. Measured elemental content (%): c, 92.52; h, 5.88; n, 1.64.
Synthetic example 27: preparation of Compounds 2-346
Figure BDA0003724720390000732
According to the preparation method of synthetic example 11, equimolar a-2-6 and equimolar b-2-6 were replaced with equimolar a-2-123 and equimolar b-2-346, respectively, to obtain compound 2-346(27.64g), having an HPLC purity of 99.96% or more. Mass spectrum m/z: 920.5038 (theoretical value: 920.5056). Theoretical element content (%) C 70 H 48 D 9 N: c, 91.26; h, 7.22; n, 1.52. Measured elemental content (%): c, 91.29; h, 7.19; n, 1.48.
Synthetic example 28: preparation of Compounds 2-377
Figure BDA0003724720390000733
According to the production method of Synthesis example 11, equimolar amounts of a-2-6, b-2-6 and c-2-6 were replaced with equimolar amounts of c-2-123, b-2-377 and c-2-123, respectively, to obtain Compound 2-377(29.21g) with an HPLC purity of 99.93% or more. Mass spectrum m/z: 1122.6853 (theoretical value: 1122.6870). Theoretical element content (%) C 85 H 82 D 3 N: c, 90.86; h, 7.89; and N, 1.25. Measured elemental content (%): c, 90.90; h, 7.92; n, 1.22.
Synthetic example 29: preparation of Compounds 2-384
Figure BDA0003724720390000734
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar c-2-123, b-2-384 and c-2-276, respectively, to obtain compound 2-384(24.11g) with an HPLC purity of 99.92% or higher. Mass spectrum m/z: 860.5074 (theoretical value: 860.5087). Theoretical element content (%) C 65 H 52 D 7 N: c, 90.65; h, 7.72; n, 1.63. Measured elemental content (%): c, 90.68; h, 7.68; n, 1.59.
Synthetic example 30: preparation of Compound 2-395
Figure BDA0003724720390000741
According to the preparation method of Synthesis example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-395, b-2-395 and c-2-289, respectively, to give compound 2-395(23.51g) with HPLC purity ≧ 99.96%. Mass spectrum m/z: 863.4446 (theoretical value: 863.4429). Theoretical element content (%) C 66 H 49 D 4 N: c, 91.73; h, 6.65; n, 1.62. Measured elemental content (%): c, 91.69; h, 6.67; n, 1.58.
Synthetic example 31: preparation of Compounds 2-399
Figure BDA0003724720390000742
According to the preparation method of synthetic example 11, equimolar a-2-6, b-2-6 and c-2-6 were replaced with equimolar a-2-399, b-2-399 and c-2-69, respectively, to obtain compound 2-399(24.05g) with an HPLC purity ≧ 99.94%. Mass spectrum m/z: 896.4979 (theoretical value: 896.4994). Theoretical element content (%) C 68 H 40 D 13 N: c, 91.03; h, 7.41; n, 1.56. Measured elemental content (%): c, 91.06; h, 7.38; and N, 1.60.
The energy levels were determined using cyclic voltammetry, in which the energy levels were determined from the relative potential values of the electrode potential values with respect to a known reference potential, and table 1 shows the HOMO level test results of the compounds prepared in the examples of the present invention.
TABLE 1 HOMO energy levels of the compounds prepared in the examples of the present invention
Figure BDA0003724720390000743
Figure BDA0003724720390000751
As can be seen from Table 1, the HOMO energy level of the hole transport layer material is between-5.02 eV and-5.19 eV, the HOMO energy level of the electron blocking layer material is between-5.23 eV and-5.29 eV, the absolute value of the difference between the HOMO value of the hole transport layer material and the HOMO value of the electron blocking layer material is more than or equal to 0eV and less than or equal to 0.25eV, and the energy level relationship can solve the problem of accumulation of holes between the electron blocking layer and the light emitting layer.
Device examples 1 to 24
The ITO glass substrate is ultrasonically cleaned for 2 times and 20 minutes each time by 5% glass cleaning solution, and then ultrasonically cleaned for 2 times and 10 minutes each time by deionized water. Ultrasonic cleaning with acetone and isopropanol for 20 min, and oven drying at 120 deg.C. Vacuum evaporating HI on the ITO substrate to form an evaporated layer with the thickness of 15nm as a hole injection layer; vacuum evaporating the compound 1-3 of the invention on the hole injection layer to form a hole transport layer, wherein the evaporation thickness is 80 nm; performing vacuum evaporation on the hole transport layer to obtain a compound 2-384 serving as an electron blocking layer, wherein the evaporation thickness is 40 nm; vacuum evaporating BH-1: BD-1 (mass ratio) to 96:4 on the electron blocking layer to form a light emitting layer, wherein the evaporation thickness is 20 nm; HB is evaporated on the luminescent layer in vacuum to be used as a hole blocking layer, and the evaporation thickness is 15 nm; performing vacuum evaporation on the hole blocking layer to form ET as an electron transport layer, wherein the evaporation thickness is 30 nm; evaporating LiF on the electron transport layer in vacuum to form an electron injection layer, wherein the evaporation thickness is 1 nm; al was vacuum-deposited on the electron injection layer as a cathode, and the deposition thickness was 70 nm.
Figure BDA0003724720390000752
Device embodiments 2-24: the compounds 1-8, 1-25, 1-36, 1-44, 1-61, 1-75, 1-107, 1-181, 1-191, 1-237, 1-253, 1-287, 1-319, 1-322, 1-336, 1-356, 1-370, 1-405, 1-470, 1-523, 1-555, 1-676 and 1-757 of the invention are respectively used for replacing the compounds 1-3 of the invention in the device example 1 as hole transport layer materials, and the compounds 2-346, 2-300, 2-69, 2-80, 2-245, 2-337, 2-377, 2-183, 2-31, 2-308, 2-300 and 2-395 of the invention are respectively used for replacing the compounds 1-3 of the invention in the device example 1 as hole transport layer materials, Organic electroluminescent devices were prepared using the same procedures as in device example 1, except that 2-289, 2-384, 2-399, 2-6, 2-167, 2-201, 2-123, 2-44, 2-245, 2-276, 2-107 generations of the compounds 2-384 of the present invention in device example 1 were used as electron blocking layer materials.
Comparative examples 1 to 20: compounds 1 to 61, compounds 1 to 370, compounds 1 to 555, compounds 1 to 676, comparative compound 1, comparative compound 2, comparative compound 3, compounds 1 to 181, compounds 1 to 319, compounds 1 to 370, compounds 1 to 405, compounds 1 to 470 and NPB were used as hole transport layer materials, respectively, instead of the compounds 1 to 3 of the present invention in device example 1, and compounds 4, comparative compound 5, compounds 2 to 69, compounds 2 to 167, compounds 2 to 107, compounds 2 to 123, compounds 2 to 183, compounds 2 to 399, TPD, compounds 2 to 123, compounds 2 to 167, compounds 2 to 183, compounds 2 to 201 and compounds 2 to 289 were used as electron blocking layer materials, respectively, instead of the compounds 2 to 384 of the present invention in device example 1, except for this, the same procedure as in device example 1 was applied to produce an organic electroluminescent device.
Comparative example 21: the ITO glass substrate is ultrasonically cleaned for 2 times and 20 minutes each time by 5% glass cleaning solution, and then ultrasonically cleaned for 2 times and 10 minutes each time by deionized water. Ultrasonic cleaning with acetone and isopropanol for 20 min, and oven drying at 120 deg.C. Vacuum evaporating HI on the ITO substrate to form an evaporated layer with the thickness of 15nm as a hole injection layer; vacuum evaporating the compounds 1-8 of the invention on the hole injection layer to form a hole transport layer, wherein the evaporation thickness is 120 nm; vacuum evaporating BH-1: BD-1 (mass ratio) to 96:4 on the hole transport layer to form a light emitting layer, wherein the evaporation thickness is 20 nm; HB is evaporated on the luminescent layer in vacuum to be used as a hole blocking layer, and the evaporation thickness is 15 nm; performing vacuum evaporation on the hole blocking layer to form ET as an electron transport layer, wherein the evaporation thickness is 30 nm; evaporating LiF on the electron transport layer in vacuum to form an electron injection layer, wherein the evaporation thickness is 1 nm; al was vacuum-deposited on the electron injection layer as a cathode, and the deposition thickness was 70 nm.
Comparative examples 22, 23: organic electroluminescent devices were produced by using the same procedures as in comparative example 21, except that the compounds 1 to 181 and 1 to 322 according to the present invention were used as hole transport layer materials, respectively, instead of the compounds 1 to 8 according to the present invention in comparative example 19.
The test software, computer, K2400 digital source meter manufactured by Keithley corporation, usa, and PR788 spectral scanning luminance meter manufactured by Photo Research corporation, usa were combined into a combined IVL test system to test the luminous efficiency of the organic electroluminescent device. The lifetime was measured using the M6000 OLED lifetime test system from McScience. The environment of the test is atmospheric environment, and the temperature is room temperature.
The results of the light emission characteristic test of the obtained organic electroluminescent device are shown in table 2. Table 2 shows the results of the test of the light emitting characteristics of the organic electroluminescent devices prepared by the compounds prepared in the inventive examples and the comparative materials.
Table 2 luminescence characteristic test of light emitting device
Figure BDA0003724720390000761
Figure BDA0003724720390000771
It can be seen from table 2 that the energy level relationship of the organic electroluminescent device of the present invention not only helps to effectively confine the holes in the light emitting layer to be combined with the electrons to form exciton luminescence, but also the exciton recombination region moves to the center of the light emitting layer, so that the accumulation of the holes at the interface between the light emitting layer and the electron blocking layer is effectively avoided, thereby improving the efficiency and lifetime of the organic electroluminescent device.
It should be understood that the present invention has been particularly described with reference to particular embodiments thereof, but that various changes in form and details may be made therein by those skilled in the art without departing from the principles of the invention and, therefore, within the scope of the invention.

Claims (10)

1. An organic electroluminescent device, comprising: an anode and a cathode which are oppositely arranged, a light-emitting layer between the anode and the cathode, an electron-blocking layer between the light-emitting layer and the anode, and a hole-transporting layer between the electron-blocking layer and the anode, characterized in that the HOMO level of the electron-blocking layer is equal to or less than the HOMO level of the hole-transporting layer, and the absolute value of the difference between the HOMO level of the hole-transporting layer and the HOMO level of the electron-blocking layer is greater than or equal to 0eV and less than or equal to 0.25eV,
the material of the hole transport layer is selected from the structure shown in the following formula 1,
Figure FDA0003724720380000011
in formula 1, Ar is 1 、Ar 2 The same or different is selected from any one of the structures shown below,
Figure FDA0003724720380000012
ring a is selected from a substituted or unsubstituted spirocyclic structure;
the R is 1 -R 5 The same or different hydrogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C6-C18 aryl;
a is a 1 Selected from 0,1, 2,3, 4 or 5; a is a 2 Selected from 0,1, 2 or 3; a is a 3 Selected from 0,1, 2,3 or 4; when two or more R's are present 1 When two or more R are present 1 Are the same or different from each other, or two adjacent R 1 Are connected with each other to form a substituted or unsubstituted ring; when two or more R's are present 5 When two or more R are present 5 Are the same or different from each other, or two adjacent R 5 Are connected with each other to form a substituted or unsubstituted ring;
n is said 1 Selected from 1,2 or 3;
said R is 0 The same or different compounds are selected from any one of hydrogen, deuterium, tritium, C1-C6 alkyl and C6-C12 aryl; the R is 0 May be substituted by one or more substituents which may be the same or different and are selected from any one of deuterium, tritium, an alkyl group of C1 to C12, and an aryl group of C6 to C12;
n is 2 Selected from 0,1, 2,3 or 4; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other, or two adjacent R 0 Are connected with each other to form a substituted or unsubstituted alicyclic ring;
the above-mentioned
Figure FDA0003724720380000013
Containing at least one deuterium or tritium;
the Ra and the Rb are the same or different and are selected from any one of hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C12 aryl;
m is 1 Selected from 0,1, 2,3 or 4; when two or more Ra are present, the two or more Ra are the same or different from each other, or two adjacent Ra are linked to each other to form a substituted or unsubstituted benzene ring;
m is 2 Selected from 0,1, 2 or 3; when two or more Rb are present, the two or more Rb may be the same or different from each other, or two adjacent Rb may be linked to each other to form a substituted or unsubstituted benzene ring;
ar is 3 Any one selected from substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C8 cycloalkyl and substituted or unsubstituted C6-C18 aryl;
said L 1 、L 2 The same or different arylene groups are selected from single bond, substituted or unsubstituted arylene groups of C6-C18.
2. An organic electroluminescent device according to claim 1, wherein the organic electroluminescent device is characterized in that
Figure FDA0003724720380000021
Selected from any one of the structures shown below,
Figure FDA0003724720380000022
the R is 0 、R 6 Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl which are the same or different; the R is 0 May be substituted with one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl; the R is 6 May be substituted by one or more substituents which may be the same or different and are selected from deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, benzeneAny one of the above groups;
n is 3 The same or different is selected from 0,1, 2,3 or 4; n is 4 The same or different is selected from 0,1, 2 or 3; when two or more R's are present 0 When two or more R are present 0 Are the same or different from each other;
b is 1 The same or different is selected from 0,1 or 2; b is 2 The same or different is selected from 0,1, 2,3 or 4; b is 3 The same or different is selected from 0,1, 2,3, 4,5 or 6; b is 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; b is 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; b is 6 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; when two or more R's are present 6 When two or more R are present 6 The same or different from each other.
3. The organic electroluminescent device as claimed in claim 1, wherein Ar is Ar 1 、Ar 2 The same or different is selected from any one of the structures shown below,
Figure FDA0003724720380000031
Figure FDA0003724720380000041
the R is 1 、R 5 、R 7 Any one of hydrogen, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and terphenyl, which are the same or different; the R is 1 May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is 5 Can be taken by one or moreSubstituted groups, wherein the substituted groups are the same or different and are any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is 7 May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl;
a is a 1 The same or different is selected from 0,1, 2,3, 4 or 5; a is a 2 The same or different is selected from 0,1, 2 or 3; a is a 3 The same or different is selected from 0,1, 2,3 or 4; a is a 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; a is a 5 The same or different is selected from 0,1, 2,3, 4,5 or 6; a is a 6 Identical or different from 0,1, 2,3, 4,5, 6,7 or 8; a is a 7 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; when two or more R's are present 1 When two or more R are present 1 Are the same or different from each other; when two or more R's are present 5 When two or more R are present 5 Are the same or different from each other;
q is a number of 1 The same or different is selected from 0,1, 2,3, 4 or 5; q is a number of 2 The same or different is selected from 0,1, 2,3 or 4; q is a number of 3 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; q is a number of 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; q is a number of 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; q is a number of 6 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; q is a number of 7 Identical or different from 0,1, 2,3, 4,5 or 6; when two or more R's are present 7 When two or more R are present 7 The same or different from each other.
4. An organic electroluminescent device according to claim 1, wherein the organic electroluminescent device is characterized in that
Figure FDA0003724720380000042
Selected from any one of the structures shown below,
Figure FDA0003724720380000043
Figure FDA0003724720380000051
the Ra, Rb and R 8 Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl and naphthyl; the Ra may be substituted by one or more substituents which may be the same or different, and are selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl; the Rb may be substituted by one or more substituents which may be the same or different and are any one selected from deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl; the R is 8 May be substituted with one or more substituents which may be the same or different, selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, naphthyl;
m is 1 Selected from 0,1, 2,3 or 4; when two or more Ra are present, two or more Ra are the same or different from each other, or two adjacent Ra are linked to each other to form a substituted or unsubstituted benzene ring;
m is 2 Selected from 0,1, 2 or 3; when two or more Rb are present, the two or more Rb may be the same or different from each other, or two adjacent Rb may be linked to each other to form a substituted or unsubstituted benzene ring;
said p is 1 The same or different is selected from 0,1, 2,3 or 4; said p is 2 The same or different ones are selected from 0,1, 2,3,4.5 or 6; said p is 3 The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; said p is 4 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; said p is 5 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; said p is 6 The same or different is selected from 0,1, 2,3, 4 or 5; said p is 7 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; said p is 8 The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; said p is 9 Identical or different from 0,1, 2,3, 4,5, 6,7,8, 9,10 or 11; said p is 10 The same or different is selected from 0,1, 2 or 3; when two or more R's are present 8 When two or more R are present 8 The same or different from each other.
5. An organic electroluminescent device according to claim 1, wherein L is 1 、L 2 The same or different is selected from a single bond or any one of the structures shown below,
Figure FDA0003724720380000061
the R is 9 Any one of hydrogen, methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl which are the same or different; the R is 9 May be substituted with one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
v is 1 The same or different is selected from 0,1, 2,3 or 4; v is 2 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; when two or more R's are present 9 When two or more R are present 9 The same or different from each other.
6. The organic electroluminescent device according to claim 1, wherein the formula 1 is selected from any one of the following structures,
Figure FDA0003724720380000062
Figure FDA0003724720380000071
Figure FDA0003724720380000081
Figure FDA0003724720380000091
Figure FDA0003724720380000101
Figure FDA0003724720380000111
Figure FDA0003724720380000121
Figure FDA0003724720380000131
Figure FDA0003724720380000141
Figure FDA0003724720380000151
Figure FDA0003724720380000161
Figure FDA0003724720380000171
Figure FDA0003724720380000181
Figure FDA0003724720380000191
Figure FDA0003724720380000201
Figure FDA0003724720380000211
Figure FDA0003724720380000221
Figure FDA0003724720380000231
Figure FDA0003724720380000241
Figure FDA0003724720380000251
Figure FDA0003724720380000261
Figure FDA0003724720380000271
Figure FDA0003724720380000281
7. the organic electroluminescent device as claimed in claim 1, wherein the electron blocking layer is made of a material selected from the group consisting of the following structures represented by formula 2,
Figure FDA0003724720380000282
in the formula 2, Ar a 、Ar b The same or different structures are selected from any one of the structures shown in the chemical formulas I to IV,
Figure FDA0003724720380000283
ring B is selected from a substituted or unsubstituted spirocyclic structure;
the R is c -R g Any one of the same or different groups selected from hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C3-C12 alicyclic ring, fused cyclic group of C6-C18 aromatic ring, and substituted or unsubstituted C6-C18 aryl;
m is a Selected from 0,1, 2 or 3; m is b Selected from 0,1, 2 or 3 or 4; when two or more R's are present c When two or more R are present c Are the same or different from each other, or two adjacent R c Are connected with each other to form a substituted or unsubstituted ring; when two or more R's are present d When two or more R are present d Are the same or different from each other, or two adjacent R d Are connected with each other to form a substituted or unsubstituted ring;
ar is c Selected from any one of the structures shown below,
Figure FDA0003724720380000291
the R is h Any one of the same or different selected from hydrogen, deuterium, tritium, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C3-C12 alicyclic ring, substituted or unsubstituted C3-C12 alicyclic ring, C6-C18 aromatic ring fused ring group, and substituted or unsubstituted C6-C18 aryl;
n is a The same or different is selected from 0,1, 2,3, 4 or 5; n is b The same or different is selected from 0,1, 2,3 or 4; n is c The same or different is selected from 0,1, 2 or 3; when two or more R's are present h When two or more R are present h Are the same or different from each other, or adjacent R h Are connected with each other to form a substituted or unsubstituted ring;
L a ~L c the same or different arylenes are selected from single bond, substituted or unsubstituted C6-C18;
the above-mentioned
Figure FDA0003724720380000292
Containing at least one deuterium or tritium.
8. An organic electroluminescent device according to claim 7, wherein the organic electroluminescent device is a single-layer organic electroluminescent deviceAr is said a 、Ar b The same or different is selected from any one of the structures shown below,
Figure FDA0003724720380000293
Figure FDA0003724720380000301
Figure FDA0003724720380000311
the R is c 、R d 、R i Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, benzocyclopropyl, benzocyclobutenyl, benzocyclopentyl, and benzocyclohexyl, which may be the same or different; the R is c May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is d May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl; the R is i May be substituted by one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl and phenyl;
m is a The same or different is selected from 0,1, 2 or 3; m is b The same or different is selected from 0,1, 2,3 or 4; m is c The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; m is d The same or different is selected from 0,1, 2,3, 4,5 or 6; m is e The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; m is f The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; m is g The same or different is selected from 0,1, 2,3, 4 or 5; when two or more R's are present c When two or more R are present c Are the same or different from each other; when two or more R's are present d When two or more R are present d Are the same or different from each other;
v is a The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; v is b The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; v is c The same or different is selected from 0,1, 2,3, 4 or 5; v is d The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10 or 11; v is e The same or different is selected from 0,1, 2,3, 4,5, 6,7,8 or 9; v is f The same or different is selected from 0,1, 2,3 or 4; v is g The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; v is h The same or different is selected from 0,1, 2,3, 4,5 or 6; v is i The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9,10, 11 or 12; when two or more R's are present i When two or more R are present i The same or different from each other.
9. An organic electroluminescent device according to claim 7, wherein Ar is c Selected from any one of the structures shown below,
Figure FDA0003724720380000312
Figure FDA0003724720380000321
Figure FDA0003724720380000331
the R is h Any one of hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl and naphthyl;
the R is h May be substituted with one or more substituents selected from any one of deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
n is a The same or different is selected from 0,1, 2,3, 4 or 5; n is b The same or different is selected from 0,1, 2,3 or 4; n is c The same or different is selected from 0,1, 2 or 3; n is d The same or different is selected from 0,1 or 2; n is e The same or different is selected from 0,1, 2,3, 4,5 or 6; n is f The same or different is selected from 0,1, 2,3, 4,5, 6,7 or 8; n is g The same or different is selected from 0,1, 2,3, 4,5, 6,7,8, 9 or 10; when two or more R's are present h When two or more R are present h The same or different from each other.
10. An organic electroluminescent device according to claim 7, wherein L is a ~L c The same or different is selected from a single bond or any one of the structures shown below,
Figure FDA0003724720380000332
the R is k Identical or different from hydrogen, deuterium, tritium, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, adamantyl, norbornyl, phenyl, biphenyl, terphenyl, benzocyclopropyl, benzocyclobutyl, benzocyclopentyl, benzocyclohexylAny one of them; said R is 9 May be substituted with one or more substituents which may be the same or different and are selected from any one of methyl, ethyl, isopropyl, tert-butyl, adamantyl, norbornyl, phenyl, biphenyl, naphthyl;
k is 1 The same or different is selected from 0,1, 2,3 or 4; k is 2 The same or different is selected from 0,1, 2,3, 4,5, 6 or 7; when two or more R's are present k When two or more R are present k Are the same or different from each other, or two adjacent R k Are linked to each other to form a substituted or unsubstituted ring.
CN202210763276.XA 2022-04-28 2022-06-30 Organic electroluminescent device Active CN114899344B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2022104714804 2022-04-28
CN202210471480 2022-04-28

Publications (2)

Publication Number Publication Date
CN114899344A true CN114899344A (en) 2022-08-12
CN114899344B CN114899344B (en) 2023-04-07

Family

ID=82729858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210763276.XA Active CN114899344B (en) 2022-04-28 2022-06-30 Organic electroluminescent device

Country Status (1)

Country Link
CN (1) CN114899344B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293516A (en) * 2018-11-03 2019-02-01 长春海谱润斯科技有限公司 A kind of tri-arylamine group compound and its organic luminescent device
CN113527181A (en) * 2021-08-12 2021-10-22 长春海谱润斯科技股份有限公司 Nitrogen-containing heterocyclic organic compound and organic light-emitting device thereof
CN113735808A (en) * 2021-09-23 2021-12-03 长春海谱润斯科技股份有限公司 Triarylamine compound and organic electroluminescent device thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293516A (en) * 2018-11-03 2019-02-01 长春海谱润斯科技有限公司 A kind of tri-arylamine group compound and its organic luminescent device
CN113527181A (en) * 2021-08-12 2021-10-22 长春海谱润斯科技股份有限公司 Nitrogen-containing heterocyclic organic compound and organic light-emitting device thereof
CN113735808A (en) * 2021-09-23 2021-12-03 长春海谱润斯科技股份有限公司 Triarylamine compound and organic electroluminescent device thereof

Also Published As

Publication number Publication date
CN114899344B (en) 2023-04-07

Similar Documents

Publication Publication Date Title
CN102617626B (en) Condensed-cyclic compound and the Organic Light Emitting Diode including this condensed-cyclic compound
CN110981899B (en) Polycyclic organoboron derivatives and electronic devices
KR102096047B1 (en) Novel heterocyclic compound for organic light emitting device and organic light emitting device comprising the same
CN109438328B (en) Condensed ring compound and organic light emitting diode including the same
CN111747938A (en) Arylamine compound and organic electroluminescent device thereof
CN115057849B (en) Triarylamine organic compound and organic light-emitting device thereof
KR102159148B1 (en) Heterocyclic compound and organic light emitting device comprising same
TW201416409A (en) Compound and organic light emitting device including the same
CN114907217B (en) Triamine compound and organic electroluminescent device thereof
CN116023275A (en) Triamine derivative and organic light-emitting device thereof
KR20150064804A (en) Compound and organic light emitting device comprising same
CN114394949A (en) Biphenylamine derivative and organic electroluminescent device thereof
EP2704225B1 (en) Organic electroluminescent element
CN113845512A (en) Compound containing heterocycle and organic electroluminescent device thereof
CN113666921A (en) Heterocyclic compound and organic electroluminescent device thereof
CN113228331A (en) Organic light emitting device
US20130328041A1 (en) Compounds having bipyridyl group and carbazole ring, and organic electroluminescent element
CN114621181B (en) Star-shaped tetramine derivative and organic electroluminescent device thereof
CN115385802A (en) Organic electroluminescent device
CN114899344B (en) Organic electroluminescent device
CN113698360A (en) Oxazole or thiazole compound and organic electroluminescent device thereof
CN112868111A (en) Organic light emitting device
CN114944459B (en) Organic electroluminescent device
CN115802781B (en) Organic electroluminescent device
CN115448870B (en) Arylamine compound containing carbazole group and organic electroluminescent device thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant